Showing results (221-230 of 320) with videos related to
Sort By:
Pageof 32
Circulation|March 4, 2021
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart AssociationTimothy D Henry, Matthew I Tomey, Jacqueline E Tamis-Holland, et al.JACC. Advances|October 21, 2024
Characteristics and Outcomes of Patients With Valvular Cardiogenic ShockRaunak M Nair, Sanchit Chawla, Feras Alkhalaileh, et al.Journal of the American Heart Association|November 23, 2019
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE TrialAnirudh Kumar, Divyang R Patel, Danielle M Brennan, et al.Pacing and Clinical Electrophysiology : PACE|January 26, 2019
Management and outcomes in mitral valve prolapse with ventricular arrhythmias undergoing ablation and/or implantation of ICDsJoseph M Bumgarner, Divyang Patel, Anirudh Kumar, et al.Circulation|November 18, 2024
Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and ObesityMichael R Zile, Barry A Borlaug, Christopher M Kramer, et al.Lancet (London, England)|March 14, 2015
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trialFaiez Zannad, Christopher P Cannon, William C Cushman, et al.European Heart Journal. Acute Cardiovascular Care|May 11, 2021
Predictors of permanent pacemaker requirement after cardiac surgery for infective endocarditisTerence E Hill, Erich L Kiehl, Nabin K Shrestha, et al.The American Journal of Medicine|July 31, 2017
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION TrialDaniel H Solomon, M Elaine Husni, Peter A Libby, et al.American Heart Journal|September 26, 2006
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trialC Michael Gibson, Ajay J Kirtane, Sabina A Murphy, et al.The American Journal of Medicine|July 11, 2006
Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromesVenu Menon, John S Rumsfeld, Matthew T Roe, et al.Pageof 32